AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 102 min read$TLRY

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray Brands (TLRY) has lost over 90% of its market value in five years, trading near $4 per share. The company reported Q1 2027 revenue of $257.1M, up 23% YoY, but cannabis revenue declined 13% YoY. Tilray posted a net loss of $0.32 per share. The cannabis industry's outlook remains uncertain, and even federal legalization may not solve Tilray's financial struggles.

Original reporting
finance.yahoo.com
Published Oct 10, 2026, 6:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 10, 2026, 6:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TLRYBearishLow
01

Why it matters

The earnings release underscores ongoing losses, likely prompting short‑term price weakness.

02

Market read

Earnings highlight challenges for Tilray and may influence sentiment across the cannabis sector.

03

What to watch

Potential upside from beverage segment growth and strategic partnerships.

Relevance 4/10Novelty 4/10Timing: post‑market release of Q1 results

Background

Tilray is a micro‑cap cannabis company trading below $5, with a history of volatility.

Company-level read

Ticker impact

$TLRYBearishMedium confidence
Context

Q1 FY2027 results show revenue growth but net loss per share of $0.32 and declining cannabis revenue.

Expected impact

likely downside as investors weigh weak profitability despite revenue growth

Evidence & confidence

The report highlights continued unprofitability and reliance on acquisitions, suggesting limited upside.

Market effects

Sector

Cannabis sector faces regulatory uncertainty and mixed earnings, pressuring peers.

Regional

U.S. cannabis stocks may see broader sell‑off.

Global

Limited to cannabis and related consumer discretionary segments.

Counterpoint

What could challenge this read

If federal legalization accelerates, TLRY could benefit from early positioning.

Key entities

  • Company
    Tilray Brands

    Cannabis producer reporting Q1 FY2027 results.

Read at source← All news

Related articles

OCT 9
$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

cantechletter.com2 min
OCT 9
$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

foodbusinessmea.com2 min
OCT 9
$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

finance.yahoo.com2 min
OCT 8
$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

finance.yahoo.com2 min
OCT 8
$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.

stocktitan.net2 min